Eastman Chemical offers asymmetric long-term upside as specialty pricing, cost savings, and molecular recycling could lift the stock from $74.09 toward a probability-weighted $126.29 over five years.
Overview
Eastman Chemical is a global specialty-materials producer organized across Advanced Materials, Additives & Functional Products, Chemical Intermediates, and Fibers, with approximately 60% of sales generated outside the United States and Canada. It sells differentiated Tritan copolyesters, Saflex interlayers, films, additives, intermediates, and acetate fibers to diversified industrial and consumer customers. **Its moat rests on application expertise, regulatory qualification, switching costs, vertical integration, and proprietary molecular recycling.** Q2 2026 demonstrated improving operating momentum: revenue reached $2,513 million, up 10% year over year and 15% sequentially; adjusted EBIT was $320 million, up 16% year over year; adjusted EBIT margin expanded to 12.7%; and adjusted EPS rose 23% to $1.97, beating consensus by 8.8%. Chemical Intermediates recovered from a $30 million loss to $58 million of adjusted EBIT, although Fibers sales fell 11%. Near-term concerns include revised operating cash flow guidance of approximately $900 million, reduced buybacks of $50 million-$100 million, $5.217 billion of borrowings, and S&P’s Negative BBB outlook. At $74.09 on August 21, 2026, the report’s base case is $117.84 and probability-weighted five-year value is $126.29. Catalysts include Kingsport debottlenecking, $125 million-$150 million of cost savings, second-half tow recovery, and newly commissioned Tritan capacity.